Cargando…
High-risk prostate cancer: value of multi-modality 3T MRI-guided biopsies after previous negative biopsies
Transrectal ultrasound-guided biopsy is the gold standard for prostate cancer detection. The latter detection rates of random systematic TRUS-guided biopsy do not exceed 44%. As a consequence other biopsy methods have been explored. One of these methods is MR-guided biopsy (MRGB), which revealed det...
Autores principales: | Fütterer, Jurgen J., Verma, Sadhna, Hambrock, Thomas, Yakar, Derya, Barentsz, Jelle O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449056/ https://www.ncbi.nlm.nih.gov/pubmed/22038330 http://dx.doi.org/10.1007/s00261-011-9818-6 |
Ejemplares similares
-
Evaluation of a robotic technique for transrectal MRI-guided prostate biopsies
por: Schouten, Martijn G., et al.
Publicado: (2011) -
Fast 3-T MR-guided transrectal prostate biopsy using an in-room tablet device for needle guide alignment: a feasibility study
por: Overduin, Christiaan G., et al.
Publicado: (2018) -
Value of PCA3 to Predict Biopsy Outcome and Its Potential Role in Selecting Patients for Multiparametric MRI
por: Leyten, Gisele H. J. M., et al.
Publicado: (2013) -
MRI-Targeted Prostate Biopsy: What Radiologists Should Know
por: Das, Chandan J, et al.
Publicado: (2020) -
MR-targeted TRUS prostate biopsy using local reference augmentation: initial experience
por: van de Ven, Wendy J. M., et al.
Publicado: (2016)